Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-25-057468)

Filing Details

Accession Number:: 0001104659-25-057468
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-06 20:01:21
Reporting Period:: 2025-06-04

Filing Date:: 2025-06-06
Accepted Time:: 2025-06-06 20:01:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1974640	Apogee Therapeutics Inc.	APGE	Biological Products, (No Disgnostic Substances) (2836)	934958665

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1983476	Carl Dambkowski	C/O Apogee Therapeutics, Inc. 221 Crescent St., Bldg. 17, Ste. 102B Waltham MA 02453	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-06-04	2,725	$36.96	241,723	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.